Neurological adverse events of immune checkpoint inhibitors and the development of paraneoplastic neurological syndromes.
Farina A, Villagrán-García M, Vogrig A, Zekeridou A, Muñiz-Castrillo S, Velasco R, Guidon AC, Joubert B, Honnorat J.
Lancet Neurol. 2024 Jan;23(1):81-94. doi: 10.1016/S1474-4422(23)00369-1.
Hashimoto's Encephalopathy: Case Series and Literature Review.
Chaudhuri J, Mukherjee A, Chakravarty A.
Curr Neurol Neurosci Rep. 2023 Apr;23(4):167-175. doi: 10.1007/s11910-023-01255-5. Epub 2023 Feb 28.
Diagnostic Approach and Treatment Regimens in Adult Patients Suffering from Antibody- mediated or Paraneoplastic Encephalitis.
Macher S, Bsteh G, Berger T, Höftberger R.
Curr Pharm Des. 2022;28(6):454-467. doi: 10.2174/1381612828666220131093259.
Autoimmune Encephalitis: Current Knowledge on Subtypes, Disease Mechanisms and Treatment.
Nissen MS, Ryding M, Meyer M, Blaabjerg M.
CNS Neurol Disord Drug Targets. 2020;19(8):584-598. doi: 10.2174/1871527319666200708133103.
Paraneoplastic neurological syndromes: a practical approach to diagnosis and management.
Binks S, Uy C, Honnorat J, Irani SR.
Pract Neurol. 2022 Feb;22(1):19-31. doi: 10.1136/practneurol-2021-003073. Epub 2021 Sep 11.
Recommended diagnostic criteria for paraneoplastic neurological syndromes.
Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, Honnorat J, Smitt PS, Vedeler Ch, Verschuuren JJ, Vincent A, Voltz R.
J Neurol Neurosurg Psychiatry. 2004 Aug;75(8):1135-40. doi: 10.1136/jnnp.2003.034447.
Autoimmune neuromyotonia.
Comperat L, Pegat A, Honnorat J, Joubert B.
Curr Opin Neurol. 2022 Oct 1;35(5):597-603. doi: 10.1097/WCO.0000000000001104. Epub 2022 Aug 19.
Paraneoplastic/autoimmune myelopathies.
Montalvo M, Flanagan EP.
Handb Clin Neurol. 2024;200:193-201. doi: 10.1016/B978-0-12-823912-4.00017-7.
Autoimmune central nervous system disorders: Antibody testing and its clinical utility.
Gilligan M, McGuigan C, McKeon A.
Clin Biochem. 2024 Apr;126:110746. doi: 10.1016/j.clinbiochem.2024.110746. Epub 2024 Mar 8.
Which antibody and which cancer in which paraneoplastic syndromes?
Gozzard P, Maddison P.
Pract Neurol. 2010 Oct;10(5):260-70. doi: 10.1136/jnnp.2010.224105.
